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was negative (with ELISA and Western blot). CD4 count was 239/
L. TFT and S. IgG levels were normal. patient was initiated on
amphotericin-B and ﬂucytosine and was continued for six weeks.
india ink still came positive for cryptococcus. CSF Cultures were
sent againwhichwas posisitve for cryptococcus neoformanswhich
was resistant to amphotericin-B but sensitive to ﬂucytosine, ﬂu-
conazole and voriconazole. CD4 counts were done again which
were 629/ L. Her KFT was normal at all times and treatment
was continued for further two weeks (total eight weeks). Patient
improved clinically headache, fever, vomitingwas relieved, did not
give consent for repeat LP and so patientwas discharged on request
onﬂuconazole400mg/day.After twoweekspatient came inaltered
sensoriumwith headadche for one day. NCCT headwas donewhich
showed obstructive hydrocephalus and patientwas posted for EVD
but patient expired on second day due to brainstem herniation.
Conclusion: We hereby present this case to sensitive clinicians
towards amphotericin resistant cryptoccocal meningitis which is
increasingly encountered in HIV as well as non-HIV patients.
http://dx.doi.org/10.1016/j.ijid.2016.02.459
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Background: Chronic Hepatitis B infection (CHBV) is a lead-
ing cause of advanced liver diseases. Mother to child transmission
accounts for most cases of CHBV infections. The risk is highest in
HBsAg+ve and HBeAg+ve mothers (transmission rate: 70%–90%).
Follicular T helper cells (TFH) have shown a preventive role against
HBV through activating the B cell mediated humoral immunity in
patients. Role of TFh cells in HBV Transmission is elusive. Hypoth-
esis: TFH cells are essential for preventing HBV transmission and
impairment of these cells may leads to vertical HBV transmission.
Methods&Materials: HBsAg+pregnantmotherswere followed
up till delivery & babies were tested for evidence of HBV trans-
mission (HBsAg or HBVDNA). Mothers were divided into 2 groups;
Transmitting (N=21; Group A) & non transmitting (N=28; Group B).
Phenotyping and functionality of TFH cells and its subsets along
with co-stimulatory molecule ICOS was performed by ﬂowcytom-
etry. Signature cytokine of TFH cells IL-21 was measured by ELISA.
NGS RNA sequencing was done in PBMCs in both groups. RNA
sequencing & FACS data was validated by qRTPCR. Correlation of
TFH with HBV DNA was done. Multivariate regression & ROC was
drawn to determine cellular predictors of HBV transmission.
Results: CD4+CXCR5+(TFH) cells were signiﬁcantly decreased
in Group A compared to Group B(6.3± 4.4% vs.17.2±5%,
p=0.001,FIG.1A) and ICOS expression on TFH was also decreased in
Group A though it was not signiﬁcant(Fig 1b).RNA sequencing data
also showed >2 fold decreased expression of TFH cell related genes
likeCD4, BCL6, ICOS, SLAMF1,CXCR5 and BAFF,BATF,CD40, BAFFR in
Group A than Group B(Fig 1c).qRT-PCR was done for validation of
these genes (Fig 1d). IL-21 was also decreased in Group A(Fig1e).
Reciprocal relation was found between TFH cells and HBV DNA(Fig
1f)and ROC showed signiﬁcance of TFH cells with cutoff 9.5 val-
ues for prediction of HBV transmission with highest speciﬁcity &
sensitivity.
Conclusion: Mother’s immunity plays an essential role in pre-
vention of vertical HBV transmission. TFH cells can be used as a
marker to predict HBV Transmission. Decreased and dysfunctional
TFH cells in HBV infected mothersleads to greater chances of HBV
transmission to their babies.
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Background: The study aim was to determine microbiologi-
cal characteristics of preservation ﬂuid (PF) cultures in solid organ
transplant (SOT) patients and to evaluate their impact on mortality
and morbidity.
Methods & Materials: A retrospective analysis of PF culture
data for SOT recipients was performed between November 1, 2013
and November 1, 2014. Deceased donor culture data and PF was
collected from the UNOS database. Additional PF culture data was
obtained locally immediately upon organ arrival to the operating
room.
Results: Analysis of data from 69 SOT recipients (Kidney 69.5%,
Kidney-Pancreas 11.5%, Pancreas 7%, and Liver 12%) revealed 19
(27.5%) positive deceased donor cultures and 43 (62.3%) PF cul-
tures. Microbial agents isolated from PF were coagulase-negative
staphylococci (52.3%) Diphtheroids (39.5%), Staphylococcus spp.,
Pseudomonas spp., and yeast (all 9.3%). Three patients (4.3%) had
same microorganism in deceased donor and PF culture. Of the 49
patients with positive cultures (either PF or deceased donor cul-
tures), 21 (42.8%) received pre-emptive antibiotic therapy within
48 hours.
One renal transplant patient developed invasive Pseudomonas
infection in the urine related to the deceased donor cultures.
There were no other incidences of invasive infections related to
the microorganisms isolated in deceased donor culture or PF cul-
ture regardless of administrationof pre-emptive antibiotic therapy.
Mortality rates at both 30 days and 90 days were not signiﬁcantly
different in recipients with positive or sterile PF cultures (30 days:
1 [2.3%] vs. 0 [0%], p=1; 90 days: 2 [4.6%] vs. 0 [0%], p=0.52). Rates of
transplant graft loss at 30 days were also not signiﬁcantly related
to the rates of positive or sterile PF cultures (6 [13.9%] vs. 0 [0%],
p=0.07).
